Print-Ready Artwork for European Pharmaceutical Cartons: Why 300 DPI and Safe Margins Matter

2026/09/09

آخرین اخبار شرکت در مورد Print-Ready Artwork for European Pharmaceutical Cartons: Why 300 DPI and Safe Margins Matter

Print-Ready Artwork for European Pharmaceutical Cartons: Why 300 DPI and Safe Margins Matter

Pharmaceutical packaging requires more than an attractive carton design. For European pharmaceutical cartons, printed information must remain clear, correctly positioned, and consistent with the approved artwork. The European Medicines Agency (EMA) reviews packaging mock-ups and printed specimens for centrally authorised medicines, highlighting the importance of accurate printed packaging and labelling.

For buyers evaluating pharmaceutical carton printing, artwork preparation should therefore be treated as part of the production specification rather than a final graphic-design step.

Why Print-Ready Artwork Matters for Pharmaceutical Cartons

A folding carton combines printing, die cutting, folding, gluing and finishing. A file that looks correct on a computer screen may still create production problems if the artwork does not match the carton structure.

Common issues include text placed too close to a cutting line, low-resolution product images, incorrect colour modes, or insufficient bleed. Packaging printing guidance also identifies bleed, dielines, image resolution, colour mode and prepress review as important elements of folding carton production.

The uploaded technical material follows the same principle. It identifies CMYK four-colour printing, CTP prepress processing and specific artwork requirements for carton production.

300 DPI: A Practical Image Resolution Requirement

For pharmaceutical packaging, small text, product information and graphic elements need to remain readable after printing and conversion into the finished carton.

The technical document specifies that print images should theoretically reach a minimum resolution of 300 dpi. It also warns that an image that looks sharp on a computer display may not have sufficient actual resolution for print production.

This is consistent with folding-carton artwork guidance that recommends evaluating effective image resolution at the final placed size rather than judging an image only from its screen appearance.

CMYK Should Be Defined Before Production

The document specifies CMYK rather than RGB for printing artwork. It explains that modern colour printing uses yellow, magenta, cyan and black inks to reproduce full-colour images.

For pharmaceutical cartons, colour should also be reviewed against the approved artwork and intended substrate. This is particularly important when different paperboards, coatings or finishing processes are involved.

Safe Margins and Bleed for Folding Cartons

The uploaded document specifies that text should remain at least 3 mm from the cutting edge. It also recommends 3–5 mm bleed so that small cutting variations do not expose unwanted white edges.

These are practical prepress controls rather than marketing claims.

Why Die-Cutting Changes the Artwork Requirement

A pharmaceutical carton is not simply a flat printed sheet. After printing, the sheet is die-cut, creased, folded and glued. The final three-dimensional structure determines where text, graphics and regulatory information appear.

For regulated pharmaceutical packaging, the EMA describes mock-ups as full-colour representations that show the final three-dimensional presentation after cutting and folding.

A Practical Selection Checklist for Buyers

When selecting a pharmaceutical carton printing supplier, buyers should confirm:

  • 300 dpi or higher for print images where applicable;

  • CMYK artwork prepared for the intended printing process;

  • at least 3 mm safe distance from cutting edges;

  • 3–5 mm bleed for carton artwork;

  • CTP and prepress workflow;

  • compatibility between paperboard, printing and finishing;

  • artwork review before mass production.

The key point is that print quality is controlled before the carton reaches the press. A supplier should be able to explain how artwork, paperboard, printing, die cutting and finishing are coordinated.

Conclusion

For European pharmaceutical cartons, choosing a printing supplier should not be based only on equipment or quoted price. A more useful approach is to review measurable artwork and production requirements.

300 dpi image resolution, CMYK colour preparation, ≥3 mm safe margins and 3–5 mm bleed provide clear technical checkpoints. Combined with CTP and controlled folding-carton production, these specifications create a more structured basis for evaluating pharmaceutical packaging printing suppliers.

The goal is not to claim that one parameter guarantees perfect printing. Instead, these measurable requirements help reduce avoidable artwork and production errors before pharmaceutical cartons enter mass production.